Centre for Molecular Microbiology and Infection, Imperial College, Exhibition Road, South Kensington, London SW7 2AZ, UK.
Nat Rev Microbiol. 2011 Mar;9(3):215-22. doi: 10.1038/nrmicro2508. Epub 2011 Feb 7.
Staphylococcus aureus bacteraemia remains very difficult to treat, and a large proportion of cases result in potentially lethal metastatic infection. Unpredictable and persistent bacteraemia in the face of highly active, usually bactericidal antibiotics is the strongest predictor of death or disseminated disease. Although S. aureus has conventionally been considered an extracellular pathogen, much evidence demonstrates that it can survive intracellularly. In this Opinion article, we propose that phagocytes, and specifically neutrophils, represent a privileged site for S. aureus in the bloodstream, offering protection from most antibiotics and providing a mechanism by which the bacterium can travel to and infect distant sites. Furthermore, we suggest how this can be experimentally confirmed and how it may prompt a change in the current paradigm of S. aureus bacteraemia and identify better treatment options for improved clinical outcomes.
金黄色葡萄球菌菌血症仍然很难治疗,很大一部分病例会导致潜在的致命转移性感染。面对高度有效的、通常具有杀菌作用的抗生素,不可预测和持续的菌血症是死亡或播散性疾病的最强预测因素。尽管金黄色葡萄球菌传统上被认为是一种细胞外病原体,但大量证据表明,它可以在细胞内存活。在这篇观点文章中,我们提出吞噬细胞,特别是中性粒细胞,代表了金黄色葡萄球菌在血液中的一个特权部位,为其提供了免受大多数抗生素的保护,并为其提供了一种可以到达和感染远处部位的机制。此外,我们还提出了如何通过实验来证实这一点,以及这可能如何促使改变目前金黄色葡萄球菌菌血症的范式,并确定更好的治疗方法,以改善临床结果。